Skip to content

H.R. 501 · 118th Congress (2023–2025)

Block, Report, and Suspend Suspicious Shipments Act

This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order or series of suspicious orders for controlled substances.

Currently, a manufacturer or distributor must report a suspicious order or series of suspicious orders to the Drug Enforcement Administration (DEA). This bill also requires a manufacturer or distributor to exercise due diligence and decline to fill the order. However, if the manufacturer or distributor resolves all of the indicators giving rise to the suspicious order or series of suspicious orders, then the bill allows the manufacturer or distributor to fill the order and choose not to report it to the DEA.

A violation is subject to civil and criminal penalties under the Controlled Substances Act.

The DEA must issue regulations specifying the indicators that give rise to a suspicious order.

Show official title

To amend the Controlled Substances Act to require registrants to decline to fill certain suspicious orders, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReported by committee

This bill’s path

This is H.R. 501’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Diana Harshbarger (R-TN-1)
Cosponsors
7 cosponsors

1 original · 6 later

3 R · 4 D

  1. Rep. Debbie Dingell (D-MI-6)· Original · Jan 25, 2023
  2. Rep. Ashley Hinson (R-IA-2)· Later · Jan 31, 2023
  3. Rep. Susie Lee (D-NV-3)· Later · Feb 2, 2023
  4. Rep. Jill N. Tokuda (D-HI-2)· Later · Feb 14, 2023
  5. Rep. Juan Ciscomani (R-AZ-6)· Later · Feb 28, 2023
  6. Rep. Kim Schrier (D-WA-8)· Later · Mar 14, 2023
  7. Rep. Marcus J. Molinaro (R-NY-19)· Later · Apr 3, 2023
Policy area
Crime and Law Enforcement
Subjects
  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances
  • Prescription drugs
  • Retail and wholesale trades

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Referred to Health

    Referred to the Subcommittee on Health.

    Sources
  2. Introduced in House

    Document: Introduced in House

    Sources
  3. Latest
    ▸ 8 committee actions · Jan 25, 2023 – May 17, 2023
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held.

      Sources
    3. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 28 - 0 .

      Sources
    4. Markup session held

      Committee Consideration and Mark-up Session Held.

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held.

      Sources
    6. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.

      Sources
    7. Committee discharged

      Committee on the Judiciary discharged.

      Sources
    8. Reported by committee

      Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-66, Part I.

      Sources
  4. Expired

    Introduced → Reported by committee → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 25, 2023 · Markup Mar 23, 2023 · Markup Mar 24, 2023 · Reported May 17, 2023H. Rept. 118-66
    1. Mar 23, 2023 · Markup

    1. H. Rept. 118-66 · May 17, 2023 · Block, Report, and Suspend Suspicious Shipments Act
  2. HouseHealthReferred Jan 25, 2023 · Markup Mar 8, 2023 · Reported Mar 8, 2023
    1. Mar 8, 2023 · Meeting

    2. Feb 1, 2023 · Hearing

  3. HouseJudiciaryReferred Jan 25, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Titles (3)
  1. Block, Report, and Suspend Suspicious Shipments Act

    Display title, Short title · Reported in House

  2. Block, Report, And Suspend Suspicious Shipments Act

    Short title · Introduced in House

  3. To amend the Controlled Substances Act to require registrants to decline to fill certain suspicious orders, and for other purposes.

    Official title · Introduced in House